American PAPR LLCis a protective equipment manufacturer. Our FELIX™100 PAPR is NIOSH-approved under the Public Health Emergency for PAPR100-N protection (99.97% filter efficiency level) effective against particulate aerosols free of oils. American PAPR LLC recommends the use of the FELIX™100 for healthcare workers responding to the COVID-19 virus. The device is manufactured and assembled in the USA within a medical equipment production facility operating under a comprehensive Quality System (QS). The FELIX™100 meets NIOSH requirements per 42 CFR Part 84 for respiratory protection against particulates.
American PAPR is a subsidiary of 3DBio Therapeutics, a biologics and bioprinting company with a focus on regenerative medicine that precision manufactures living tissues to allow replacement of each individual patient’s parts with tissues designed and created specifically for them. 3DBio has developed unique capabilities toward the creation of living tissue implants for therapeutic applications. The technology platforms include a full suite of features to meet the FDA’s requirements for therapeutic manufacturing, including novel and proprietary: 3D-bioprinter (GMPrint™), bio-ink (ColVivo™), and cell processes. In pre-clinical studies the platform has demonstrated the ability to generate functioning living tissues.